Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1263
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG NO:BN0119002-
dc.date.accessioned2023-01-17T07:15:56Z-
dc.date.available2023-01-17T07:15:56Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1263-
dc.description.abstractBackground and objectives Pregnancy-induced hypertension (PIH) is one of medical disorder of pregnancy contributing significantly to maternal and fetal morbidity and mortality. It is progressive disease with a variable mode of presentation and rate of progression. Preeclampsia has contributed to both maternal and perinatal morbidity and mortality globally in developing as well as developed countries. This study is undertaken to know the haematological, biochemical and coagulative derangement in preeclampsia and further access the prognosis and severity of the complications and thus will help as a treatment guide for cases of preeclampsia and eclampsia.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectPregnancy induced hypertension (PIH), HELLP, prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT).en_US
dc.titleClinical and diagnostic markers in patients With pregnancy induced hypertensionhospital Based observational study.en_US
dc.typeDissertationsen_US
Appears in Collections:Pathology

Files in This Item:
File Description SizeFormat 
RegNoBN0119002.pdf9.77 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.